Any links to third-party websites or content are provided merely as a convenience and Helius makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any such information. The inclusion of any third-party link or content on the Site does not imply an endorsement or recommendation by Helius or any relationship between Helius and any third party. Your use of any such third-party content, site, or platform is at your own risk and will be governed by such third-party’s terms and policies.
Join Helius at this year’s CSM in Boston, MA, and learn more about PoNS Therapy.
Note: The device has been authorized in Australia as a non-implantable neurostimulator intended for short-term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait. It is not yet commercially available in Australia.
Listen to PoNS’ recent appearance on The MSing Link podcast hosted by Dr. Gretchen Hawley. In this episode, Dr. Hawley interviews Whitney Patrickson Director of PT at Helius Medical, and Dr. Naseem Chatiwala.
Individual results and patient experiences vary.
Speak to your physician to determine if PoNS is right for you.
A first-of-its-kind technology is boosting the benefit of physical therapy for MS patients through electrical pulses that aim to ‘rewire’ the brain and activate neural pathways.
Shepherd Center has joined Helius Medical Technologies, Inc.’s Therapeutic Experience Program (TEP).
Neurological wellness company Helius Medical Technologies launched its breakthrough Portable Neuromodulation Stimulator (PoNS) to help multiple sclerosis (MS) patients who struggle to walk.